Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats - PubMed (original) (raw)
Affiliations
- PMID: 7635426
Free article
Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats
P R Sinclair et al. Hepatology. 1995 Aug.
Free article
Abstract
Ascorbate was previously shown to suppress accumulation of uroporphyrin (URO) in cultured chick embryo hepatocytes and to competitively inhibit microsomal oxidation of uroporphyrinogen catalyzed by cytochrome P4501A2. Here we used the Osteogenic Disorder Shionogi (ODS) mutant rat, which cannot synthesize ascorbic acid, to examine the in vivo effect of ascorbic acid on hepatic URO accumulation caused by treatment with 3-methylcholanthrene (MC) and 5-aminolevulinate (ALA). Female mutant rats maintained on three levels of dietary ascorbate (15,200, and 800 ppm) were treated for a total of 24 days. On the 11th and 16th days, rats were administered 3-methylcholanthrene, and 5-aminolevulinate was present continuously in the drinking water from day 14. Hepatic URO accumulated at the two lowest ascorbate levels, but not at 800 ppm ascorbate. The latter dose produced normal hepatic ascorbate levels. Plasma ascorbate levels were proportional to the hepatic values. Male rats also accumulated URO at the low dietary dose of ascorbic acid. The methylcholanthrene-induced increase in microsomal levels of CYP1A1 and CYP1A2, total cytochrome P450, and activities of uroporphyrinogen oxidation and ethoxyresorufin deethylase were not affected by the dietary level of ascorbate. Neither male nor female Fischer 344 rats accumulated URO when treated with the MC/ALA regime. Hepatic ascorbate concentrations in these rats were five-fold to seven-fold higher than they were in mutant rats that developed uroporphyria on 150 ppm dietary ascorbate. In ODS rats fed ascorbate at 90 but not 900 ppm in the diet, hexachlorobenzene caused hepatic URO accumulation, indicating that the effect of ascorbic acid is not unique to the regimen using methylcholanthrene.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Ascorbic acid inhibition of cytochrome P450-catalyzed uroporphyrin accumulation.
Sinclair PR, Gorman N, Walton HS, Bement WJ, Jacobs JM, Sinclair JF. Sinclair PR, et al. Arch Biochem Biophys. 1993 Aug 1;304(2):464-70. doi: 10.1006/abbi.1993.1376. Arch Biochem Biophys. 1993. PMID: 8346921 - Absolute requirement for iron in the development of chemically induced uroporphyria in mice treated with 3-methylcholanthrene and 5-aminolevulinate.
Nakano K, Ishizuka M, Sakamoto KQ, Fujita S. Nakano K, et al. Biometals. 2009 Apr;22(2):345-51. doi: 10.1007/s10534-008-9171-6. Epub 2008 Oct 28. Biometals. 2009. PMID: 18956144 - CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron.
Sinclair PR, Gorman N, Walton HS, Bement WJ, Dalton TP, Sinclair JF, Smith AG, Nebert DW. Sinclair PR, et al. Toxicol Appl Pharmacol. 2000 Jan 1;162(1):60-7. doi: 10.1006/taap.1999.8832. Toxicol Appl Pharmacol. 2000. PMID: 10631128 - Cytochrome P450 and its interactions with the heme biosynthetic pathway.
De Matteis F, Marks GS. De Matteis F, et al. Can J Physiol Pharmacol. 1996 Jan;74(1):1-8. Can J Physiol Pharmacol. 1996. PMID: 8963944 Review. - A rational approach for improving the ascorbate antineoplastic activity.
Bocci V, Zanardi I, Travagli V. Bocci V, et al. Cancer Invest. 2014 Mar;32(3):81-4. doi: 10.3109/07357907.2013.877477. Cancer Invest. 2014. PMID: 24499108 Review. No abstract available.
Cited by
- Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.
Sinclair PR, Gorman N, Dalton T, Walton HS, Bement WJ, Sinclair JF, Smith AG, Nebert DW. Sinclair PR, et al. Biochem J. 1998 Feb 15;330 ( Pt 1)(Pt 1):149-53. doi: 10.1042/bj3300149. Biochem J. 1998. PMID: 9461503 Free PMC article. - Role of Vitamin C in Skin Diseases.
Wang K, Jiang H, Li W, Qiang M, Dong T, Li H. Wang K, et al. Front Physiol. 2018 Jul 4;9:819. doi: 10.3389/fphys.2018.00819. eCollection 2018. Front Physiol. 2018. PMID: 30022952 Free PMC article. Review. - Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.
Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE. Egger NG, et al. Dig Dis Sci. 2002 Feb;47(2):419-26. doi: 10.1023/a:1013746828074. Dig Dis Sci. 2002. PMID: 11855561
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical